Skip to main content

Frontier Bio

HardwareHayward, CA, USAFounded 2018· One of 1739 Hardware companies tracked by AMPulse

Develops the FLUX-1 bioprinter and lab-grown human tissues (e.g., lung, blood vessels) using electro-hydrodynamic printing (EHDP) and conventional bioprinting technologies for regenerative medicine and animal testing alternatives.

CEO / Founder
Eric Bennett
Team Size
11-50
Stage
Active
Total Funding
$4.1M
Latest Round
Seed
Key Investors
National Science Foundation; America’s Seed Fund; Angel investors; 100 Plus Capital; Asymmetry Ventures; Hatcher+; Immortal Dragons; Made Noble Companies

Technology & Products

Key Products

FLUX-1 bioprinter; Tissue-engineered blood vessels (TEBVs); Lab-grown lung tissue; Neural tissue models; Blood-brain barrier chips

Technological Advantage

Proprietary EHDP technology achieves near 100% cell survivability vs. industry standard ~80%, enabling complex tissue structures like lung alveoli; defensible IP from NSF SBIR grants and client projects.

Differentiation

Value Proposition

Provides high-precision bioprinted human tissues that replace animal testing, reduce drug development costs by up to 50%, and offer scalable solutions for organ transplantation, with tissue products generating $5.2M in sales.

How They Differentiate

FLUX-1 bioprinter offers 3x higher cell survivability (100% vs. ~80%) and integrates EHDP for finer resolution compared to Allegro 3D's extrusion-based systems; generates revenue from tissue sales while competitors focus on research-only models.

Market & Competition

Target Customers

Pharmaceutical companies, medical device manufacturers, academic research institutions, hospitals

Industry Verticals

Biotechnology; Pharmaceuticals; Medical Devices; Research & Development

Competitors

Allegro 3D; PepGel; Wernig Laboratory; StemCellerant

Growth & Milestones

Growth Metrics

Revenue from tissue products reached $5.2M; team size 1-25 employees; nominated for 3D Printing Industry Awards 2024.

Major Milestones

Developed FLUX-1 bioprinter; Bioprinted complex microscale lung tissue; Secured NSF SBIR grant; Achieved $5.2M in tissue sales; Partnerships with Mayo Clinic and Intuitive Surgical

Notable Customers

Mayo Clinic; Intuitive Surgical